Home › Research › Biomarkers
Plasma biomarkers of neurodegeneration and neuroinflammation in intracranial atherosclerotic disease
Caiyan Liu, Anqi Cheng, Yinxi Zou, Hebo Wang, Zhibing Ai, Shiwen Wu, Linwen Liu, Mingli Li et al.. Brain communications, 2026-04-07
Topic: Plasma and spinal-fluid biomarkers
Plain-language summary
In multivariable analyses, none of the plasma biomarkers were significantly associated with cognitive impairment. In contrast, intracranial atherosclerotic stenosis itself was independently associated with cognitive impairment in a graded manner (asymptomatic stenosis <50%: OR = 2.48; asymptomatic stenosis ≥50%: OR = 2.65; symptomatic stenosis: OR = 4.14). These findings indicate that although plasma biomarkers of neurodegeneration and neuroinflammation are altered in advanced intracranial atherosclerotic stenosis, they do not explain the associated cognitive impairment. Our results support reconceptualizing intracranial atherosclerotic stenosis not only as a stroke-prone vascular disorder but also as a covert threat to brain health and cognition. Early identification and aggressive management of intracranial atherosclerotic stenosis, even before conventionally 'significant' stenosis or symptoms, are warranted.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Liu, C., Cheng, A., Zou, Y., Wang, H., Ai, Z., Wu, S., et al. (2026). Plasma biomarkers of neurodegeneration and neuroinflammation in intracranial atherosclerotic disease. Brain communications. https://doi.org/10.1093/braincomms/fcag125
Vancouver
Liu C, Cheng A, Zou Y, Wang H, Ai Z, Wu S, et al. Plasma biomarkers of neurodegeneration and neuroinflammation in intracranial atherosclerotic disease. Brain communications. 2026. doi:10.1093/braincomms/fcag125. PMID: 42158847.
BibTeX
@article{liu2026-42158847,
author = {Liu, Caiyan and Cheng, Anqi and Zou, Yinxi and Wang, Hebo and Ai, Zhibing and Wu, Shiwen and Liu, Linwen and Li, Mingli and others},
title = {{Plasma biomarkers of neurodegeneration and neuroinflammation in intracranial atherosclerotic disease}},
journal = {Brain communications},
year = {2026},
doi = {10.1093/braincomms/fcag125},
pmid = {42158847},
url = {https://doi.org/10.1093/braincomms/fcag125}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.
Key findings
- In multivariable analyses, none of the plasma biomarkers were significantly associated with cognitive impairment.
- In contrast, intracranial atherosclerotic stenosis itself was independently associated with cognitive impairment in a graded manner (asymptomatic stenosis <50%: OR = 2.48; asymptomatic stenosis ≥50%: OR = 2.65; symptomatic stenosis: OR = 4.14).
- These findings indicate that although plasma biomarkers of neurodegeneration and neuroinflammation are altered in advanced intracranial atherosclerotic stenosis, they do not explain the associated cognitive impairment.
- Our results support reconceptualizing intracranial atherosclerotic stenosis not only as a stroke-prone vascular disorder but also as a covert threat to brain health and cognition.
- Early identification and aggressive management of intracranial atherosclerotic stenosis, even before conventionally 'significant' stenosis or symptoms, are warranted.
New to this subject? Start with our plain-English guide: Blood tests & biomarkers →
Study details
- Participants403
- Effect sizeOR = 2.48; OR = 2.65; OR = 4.14
- Evidence strengthLow
How this study scored 63/100
Published in a leading specialty journal. Scored zero for study design and randomized / blinded because the record does not state it. We have no data on journal's citation record, times cited, citations per year, impact for its field and year, cited by studies here, still being cited, senior author's track record, institution's track record, multicenter collaboration and free to read, so those were left out: it earned 35 of the 56 points we could judge it on, which is 63 out of 100.
| Component | Points | Why |
|---|---|---|
| Journal tier | 9 / 10 | Tier 2 — leading specialty journal (Brain communications) |
| Journal's citation record | — / 4 | No journal record from OpenAlex — left out of this score |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 5 / 5 | 2026 — within 1 year(s) of the newest study here |
| Sample size | 2 / 4 | 403 participants |
| Effect reported | 3 / 3 | Effect reported with a statistic (interval, p-value, ratio or similar) |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | — / 7 | No citation count (not found in OpenAlex) — left out of this score |
| Citations per year | — / 5 | No citation count or no year — left out of this score |
| Impact for its field and year | — / 6 | No field-weighted citation impact (OpenAlex has none yet) — left out of this score |
| Cited by studies here | — / 6 | Not yet checked against this library's citation graph — left out of this score |
| Still being cited | — / 4 | No yearly citation counts — left out of this score |
| Senior author's track record | — / 4 | Senior author's record not available — left out of this score |
| Institution's track record | — / 3 | No institution listed in OpenAlex — left out of this score |
| Multicenter collaboration | — / 3 | Institutions not listed — left out of this score |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 42158847) |
| Free to read | — / 2 | Access not recorded — left out of this score |
| Points | 35 / 56 | Scored on 10 of 20 parts. We have no data for the rest, so they are left out: 35 of the 56 points we could judge it on is 63 out of 100. |
| Total | 63 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
Free copy unknown: no free-copy check has an answer for this record yet. That does not mean it is paywalled.
Related
Studies in the library that share something with this one. The line above each title says what.
Related studies in Biomarkers from nearby years
Also tagged “amyloid-angiopathy”
228 studies in the library carry the topic tag “amyloid-angiopathy”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 228 tagged studies.